BioSense News


BioSense Global CEO moderates panel discussion: China Therapeutics Investors

| Communications

BioSense Global CEO, Andy Li, is invited as a moderator to lead a panel discussion at the Redefining Early Stage Investment (RESI) Conference on January 9th, 2018 in San Francisco. At the event Mr. Li and his fellow panelists Forest Xu, Jim Liu, and Lu Han will explore and explain the Chinese therapeutic industry.